Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies

[1]  W. Cahn,et al.  Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study , 2019, International journal of epidemiology.

[2]  Shuyang Zhang,et al.  C-reactive protein for predicting cardiovascular and all-cause mortality in type 2 diabetic patients: A meta-analysis. , 2019, Cytokine.

[3]  Xuebi Xu,et al.  C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis , 2019, Bioscience reports.

[4]  Lihong Chen,et al.  Pretransplant C-reactive protein as a prognostic marker in allogeneic stem cell transplantation , 2019, Medicine.

[5]  K. Rahimi,et al.  Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies , 2019, Heart.

[6]  Liang Cheng,et al.  Exposing the Causal Effect of C-Reactive Protein on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study , 2018, Front. Genet..

[7]  James Y. Dai,et al.  Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. , 2018, International journal of epidemiology.

[8]  W. Guo,et al.  Plasma C-Reactive Protein and Abdominal Aortic Aneurysm: A Mendelian Randomization Analysis , 2018, Chinese medical journal.

[9]  Stephen R. Williams,et al.  Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. , 2018, American journal of human genetics.

[10]  G. Fond,et al.  C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review , 2018, Front. Psychiatry.

[11]  R. Noordam,et al.  High-sensitivity C-reactive protein, low-grade systemic inflammation and type 2 diabetes mellitus: A two-sample Mendelian randomization study. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  Qiusong Chen,et al.  Prognostic value of pre-therapy C-reactive protein level in diffuse large B-cell lymphoma: a meta-analysis , 2018, Leukemia & lymphoma.

[13]  Zhihong Li,et al.  Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis , 2018, PloS one.

[14]  S. Larsson,et al.  Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis , 2017, British Medical Journal.

[15]  S. Peng,et al.  C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[16]  B. Horta,et al.  Inflammatory Biomarkers and Risk of Schizophrenia , 2017, JAMA psychiatry.

[17]  Wenfeng Li,et al.  Prognostic role of C-reactive protein in patients with nasopharyngeal carcinoma , 2017, Medicine.

[18]  C. Schooling,et al.  Inflammation and bone mineral density: A Mendelian randomization study , 2017, Scientific Reports.

[19]  J. Golledge,et al.  Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease. , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[20]  K. Khunti,et al.  Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence , 2017, European Journal of Epidemiology.

[21]  H. Campbell,et al.  Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies , 2017, British Medical Journal.

[22]  Lei Zhang,et al.  Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. , 2017, Atherosclerosis.

[23]  E. Giovannucci,et al.  Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies , 2017, World journal of gastroenterology.

[24]  J. Ioannidis.  Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews , 2017, British Journal of Sports Medicine.

[25]  U. Pastorino,et al.  C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis , 2017, European Respiratory Review.

[26]  M. Totzeck,et al.  Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis , 2017, Scientific Reports.

[27]  Gaofeng Zhang,et al.  Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis , 2016, PloS one.

[28]  Douglas K Owens,et al.  Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[29]  G. Sergi,et al.  Inflammation and frailty in the elderly: A systematic review and meta-analysis , 2016, Ageing Research Reviews.

[30]  Yanbing Zhou,et al.  Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis , 2016, Oncotarget.

[31]  Jon White,et al.  Selecting instruments for Mendelian randomization in the wake of genome-wide association studies , 2016, International journal of epidemiology.

[32]  U. Pastorino,et al.  Baseline C-Reactive Protein Level Predicts Survival of Early-Stage Lung Cancer: Evidence from a Systematic Review and Meta-Analysis , 2016, Tumori.

[33]  G. Colditz,et al.  Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[34]  James T. Elder,et al.  Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study , 2016, PLoS medicine.

[35]  B. Nordestgaard,et al.  Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population. , 2016, The British journal of psychiatry : the journal of mental science.

[36]  Jeongseon Kim,et al.  Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis , 2015, Cancer Causes & Control.

[37]  D. Greenwood,et al.  Circulating C-Reactive Protein and Breast Cancer Risk—Systematic Literature Review and Meta-analysis of Prospective Cohort Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[38]  M. Berk,et al.  C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications , 2015, Molecular Psychiatry.

[39]  Tian Xu,et al.  C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies. , 2015, International journal of cardiology.

[40]  You Luo,et al.  Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis. , 2015, Molecular and clinical oncology.

[41]  Evelyn Barron,et al.  This Work Is Licensed under a Creative Commons Attribution 4.0 International License Blood-borne Biomarkers of Mortality Risk: Systematic Review of Cohort Studies , 2022 .

[42]  P. Ridker,et al.  Plasma C-Reactive Protein and Risk of Breast Cancer in Two Prospective Studies and a Meta-analysis , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[43]  Stephen Burgess,et al.  Mendelian randomization: where are we now and where are we going? , 2015, International journal of epidemiology.

[44]  G. Hansson,et al.  Anti-inflammatory therapies for atherosclerosis , 2015, Nature Reviews Cardiology.

[45]  Yun-Jiu Cheng,et al.  Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis , 2015, Clinics.

[46]  O. Franco,et al.  Pleiotropy among Common Genetic Loci Identified for Cardiometabolic Disorders and C-Reactive Protein , 2015, PloS one.

[47]  E. Riboli,et al.  Association of CRP genetic variants with blood concentrations of C‐reactive protein and colorectal cancer risk , 2015, International journal of cancer.

[48]  Cuifang Fan,et al.  C‐reactive protein plays a marginal role in cognitive decline: a systematic review and meta‐analysis , 2015, International journal of geriatric psychiatry.

[49]  Z. Wang,et al.  Role of Pre-procedural C-reactive Protein Level in the Prediction of Major Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention: a Meta-analysisof Longitudinal Studies , 2015, Inflammation.

[50]  Ying Huang,et al.  Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis , 2015, Therapeutics and clinical risk management.

[51]  J. Gómez-Reino,et al.  Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis , 2015, RMD Open.

[52]  G. Pond,et al.  Prognostic Impact of C-Reactive Protein in Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis , 2014, Oncology Research and Treatment.

[53]  B. Nordestgaard,et al.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study. , 2014, Schizophrenia bulletin.

[54]  B. Nordestgaard,et al.  Elevated C-Reactive Protein, Depression, Somatic Diseases, and All-Cause Mortality: A Mendelian Randomization Study , 2014, Biological Psychiatry.

[55]  Tao Xi,et al.  C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis , 2014, Cancer Causes & Control.

[56]  Paul M Ridker,et al.  Anti-inflammatory therapies for cardiovascular disease. , 2014, European heart journal.

[57]  Hua Xu,et al.  Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[58]  S. Bojesen,et al.  Increased body mass index, elevated C-reactive protein, and short telomere length. , 2014, The Journal of clinical endocrinology and metabolism.

[59]  J. Ioannidis,et al.  Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials , 2014, BMJ : British Medical Journal.

[60]  O. Franco,et al.  Dissecting the relationship between high-sensitivity serum C-reactive protein and increased fracture risk: the Rotterdam Study , 2014, Osteoporosis International.

[61]  Jue-min Fang,et al.  Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis , 2014, Asian journal of andrology.

[62]  Chien-Chang Lee,et al.  Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis , 2014, BMJ Open.

[63]  K. Maruyama,et al.  C-Reactive Protein and Cardiovascular Disease in East Asians: A Systematic Review , 2014, Clinical Medicine Insights. Cardiology.

[64]  L. Blizzard,et al.  Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis , 2013, Annals of the Rheumatic Diseases.

[65]  J. Ioannidis.  Clarifications on the application and interpretation of the test for excess significance and its extensions , 2013 .

[66]  B. Nordestgaard,et al.  Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation , 2013, Circulation.

[67]  T. D. Clos.  Pentraxins: structure, function, and role in inflammation. , 2013 .

[68]  J. Ioannidis,et al.  Bias in associations of emerging biomarkers with cardiovascular disease. , 2013, JAMA internal medicine.

[69]  Lin Zhou,et al.  Prognostic Role of C-Reactive Protein in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis , 2013, International journal of medical sciences.

[70]  D. Blacker,et al.  The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[71]  W. Bao,et al.  Inflammatory Markers and Risk of Type 2 Diabetes , 2012, Diabetes Care.

[72]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.

[73]  John P A Ioannidis,et al.  Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study , 2011, BMJ : British Medical Journal.

[74]  L. C. Correia,et al.  Proteína C-reativa e prognóstico em síndromes coronarianas agudas: revisão sistemática e metanálise , 2011 .

[75]  P. Mitchell,et al.  A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. , 2011, Survey of ophthalmology.

[76]  J. Gallacher,et al.  The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study. , 2011, Clinical science.

[77]  P. Elliott,et al.  Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.

[78]  J. Danesh,et al.  Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011, BMJ : British Medical Journal.

[79]  Richard D Riley,et al.  Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.

[80]  V. Salomaa,et al.  C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies. , 2011, European journal of cancer.

[81]  B. Nordestgaard,et al.  C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach , 2010, Thorax.

[82]  T. Merriman,et al.  A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation , 2010, PLoS medicine.

[83]  B. Nordestgaard,et al.  Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population. , 2010, Journal of the American College of Cardiology.

[84]  T. Frayling,et al.  C-reactive protein levels and body mass index: Elucidating direction of causation through reciprocal Mendelian randomization , 2010, International Journal of Obesity.

[85]  W. Fraser,et al.  Inflammatory Cytokines and Spontaneous Preterm Birth in Asymptomatic Women: A Systematic Review , 2010, Obstetrics and gynecology.

[86]  B. Nordestgaard,et al.  C-Reactive Protein and Risk of Venous Thromboembolism in the General Population , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[87]  B. Nordestgaard,et al.  C-reactive protein and all-cause mortality--the Copenhagen City Heart Study. , 2010, European heart journal.

[88]  Keith R. Abrams,et al.  Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease , 2010, PLoS medicine.

[89]  Wei-Qing Chen,et al.  Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies , 2010, Heart.

[90]  S. Bojesen,et al.  C-reactive protein and the risk of cancer: a mendelian randomization study. , 2010, Journal of the National Cancer Institute.

[91]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[92]  J. Ioannidis,et al.  Assessment of claims of improved prediction beyond the Framingham risk score. , 2009, JAMA.

[93]  John P.A. Ioannidis,et al.  Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses , 2009, Canadian Medical Association Journal.

[94]  J. Beckmann,et al.  Association between C-reactive protein and adiposity in women. , 2009, The Journal of clinical endocrinology and metabolism.

[95]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[96]  Shahrul Mt-Isa,et al.  Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. , 2009, JAMA.

[97]  B. Biccard,et al.  A meta‐analysis of the utility of C‐reactive protein in predicting early, intermediate‐term and long term mortality and major adverse cardiac events in vascular surgical patients , 2009, Anaesthesia.

[98]  D. Melzer,et al.  Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes , 2008, Diabetologia.

[99]  Tom R. Gaunt,et al.  The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants , 2008, PloS one.

[100]  Meena Kumari,et al.  Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study , 2008, PloS one.

[101]  Jackie A Cooper,et al.  Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream , 2008, PLoS medicine.

[102]  J. Sunyer,et al.  Systemic inflammation, genetic susceptibility and lung function , 2008, European Respiratory Journal.

[103]  J. Jahnsen,et al.  C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study , 2008, Gut.

[104]  P. Ridker.  High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. , 2008, Clinical chemistry.

[105]  T. Lehtimäki,et al.  Relationship between leptin and C-reactive protein in young Finnish adults. , 2007, The Journal of clinical endocrinology and metabolism.

[106]  Nikolaos A Patsopoulos,et al.  Uncertainty in heterogeneity estimates in meta-analyses , 2007, BMJ : British Medical Journal.

[107]  Debbie A Lawlor,et al.  Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[108]  David Moher,et al.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.

[109]  Juan P Casas,et al.  Insight into the nature of the CRP-coronary event association using Mendelian randomization. , 2006, International journal of epidemiology.

[110]  Tom R. Gaunt,et al.  C-reactive protein and its role in metabolic syndrome: mendelian randomisation study , 2005, The Lancet.

[111]  T. Seemungal,et al.  Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD , 2005, Chest.

[112]  J. Soriano,et al.  C-reactive protein in patients with COPD, control smokers and non-smokers , 2005, Thorax.

[113]  Shah Ebrahim,et al.  Association of C-Reactive Protein With Blood Pressure and Hypertension: Life Course Confounding and Mendelian Randomization Tests of Causality , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[114]  A Senthilselvan,et al.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.

[115]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[116]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[117]  P. Ridker,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[118]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[119]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[120]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[121]  J H Lubin,et al.  On power and sample size for studying features of the relative odds of disease. , 1990, American journal of epidemiology.

[122]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[123]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[124]  F. Gao,et al.  Prognostic value of serum C-reactive protein in pancreatic cancer : a meta-analysis , 2018 .

[125]  Shaokai Zhang,et al.  Prognostic role of C-reactive protein in breast cancer : an updated systematic review and meta-analysis , 2016 .

[126]  Bin Liu,et al.  C-reactive protein and risk of fracture: a systematic review and dose–response meta-analysis of prospective cohort studies , 2014, Osteoporosis International.

[127]  W. Guo,et al.  Prognostic value of circulating inflammatory factors in non-small cell lung cancer: a systematic review and meta-analysis. , 2014, Cancer biomarkers : section A of Disease markers.

[128]  Weihong Ding,et al.  The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis. , 2014, Urologic oncology.

[129]  M. Sade-Feldman,et al.  Chronic inflammation and cancer: suppressing the suppressors , 2013, Cancer Immunology, Immunotherapy.

[130]  Haiyong Wang,et al.  Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[131]  L. Pan,et al.  Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[132]  Demetre Labadarios,et al.  Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. , 2010, Nutrition.

[133]  P. Fein,et al.  Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients. , 2005, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.